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Research
Exposure to environmental toxicants is associ-
ated with numerous disease outcomes, many 
of which involve underlying immune and 
inflammatory dysfunction (Dietert et al. 
2010). Mounting epidemiological evidence 
suggests that proper function of the immune 
system is a major determinant of health 
across the life course (Dietert et al. 2010). 
For example, those with childhood asthma 
may have an elevated risk of developing lung 
cancer (Dietert et al. 2010), and among indi-
viduals ≥ 87 years old, immune dysregula-
tion has been linked with dementia (Katsel 
et al. 2009). Exposure to environmental toxi-
cants, therefore, may cause life-long changes 
in response to infectious agents, in immune 
homeostasis, and in overall physical and   
mental health (Dietert et al. 2010).
One group of environmental toxi-
cants affecting immune system function is 
endocrine-disrupting compounds (EDCs) 
(Chalubinski and Kowalski 2006). In 1996, 
the U.S. Congress first recognized EDCs as a 
public health concern when it mandated that 
the U.S. Environmental Protection Agency 
(EPA) develop a way to identify and moni-
tor EDCs in the environment (Endocrine 
Society 2009). EDCs are substances found 
in food, personal care and other consumer 
products, pharmaceuticals, and the environ-
ment that have deleterious effects on human 
health, homeostasis, metabolism, and repro-
duction (Diamanti-Kandarakis et al. 2009). 
Synthetic EDCs form a diverse group of 
chemicals primarily used in pesticides, indus-
trial chemicals, pharmaceuticals, and personal 
care products (Chalubinski and Kowalski 
2006). Sources of exposure to EDCs can 
vary widely, ranging from occupational to 
in utero exposures (Barr et al. 2007). The sta-
bility (among other characteristics) of many 
EDCs that makes these substances beneficial 
for industry also means that high levels of 
these chemicals can be detected in water, air, 
and soil even years after being banned from 
use, which results in extended windows of 
time during which humans may be exposed 
(Diamanti-Kandarakis et al. 2009). Although 
the exact physiological mechanisms of action 
are unknown for many EDCs, they mimic 
or affect hormones (Diamanti-Kandarakis 
et al. 2009). Despite increasing research 
on the effects of EDCs on human health, 
controversy surrounds the issue of what 
concentrations—if any—of these chemicals 
are safe for human use.
The industrial chemical bisphenol A 
(BPA) is a prevalent EDC in human prod-
ucts and environments (Vandenberg et al. 
2010; Welshons et al. 2006). BPA (4,4´-iso-
propylidenediphenol) is used primarily as a 
component of polycarbonate plastics, epoxy 
resins, and dental sealants, with > 800 million 
kg BPA produced each year in the United 
States alone (Diamanti-Kandarakis et al. 
2009). Among the many health effects asso-
ciated with BPA exposure, this chemical has 
been linked with abnormal male and female 
reproductive organ development in animals 
(Vandenberg et al. 2010) and sperm anoma-
lies in humans (Meeker et al. 2010).
According to U.S. EPA guidelines, safe 
levels of BPA intake are 50 μg/kg body 
weight/day, assuming that the main source 
of exposure is from ingestion. In a recent 
analysis of 2005–2006 National Health and 
Nutrition Examination Survey (NHANES) 
data, the median daily intake of BPA in the 
United States was estimated to be 0.034   
μg/kg/day, which is well below the U.S. 
EPA guidelines of 50 μg/kg/day (Lakind and 
Naiman 2010). Nevertheless, studies sug-
gest that the U.S. EPA guidelines and the 
conclusion that current dietary intake levels 
are safe should be reevaluated (Vandenberg 
et al. 2010). First, low-dose exposures to BPA 
(> 200 times below the U.S. EPA recom-
mended dose) in pregnant mice negatively 
affected mammary gland development of 
female offspring by increasing ductal area and 
extension, promoting fat pad maturation, and 
decreasing epithelial cell size (Vandenberg 
et al. 2007). In addition, tumor-promoting 
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Ba c k g r o u n d: Exposure to environmental toxicants is associated with numerous disease outcomes, 
many of which involve underlying immune and inflammatory dysfunction. 
oBjectives: To address the gap between environmental exposures and immune dysfunction, we 
investigated the association of two endocrine-disrupting compounds (EDCs) with markers of 
immune function. 
Me t h o d s : Using data from the 2003–2006 National Health and Nutrition Examination Survey, we 
compared urinary bisphenol A (BPA) and triclosan levels with serum cytomegalovirus (CMV) anti-
body levels and diagnosis of allergies or hay fever in U.S. adults and children ≥ 6 years of age. We 
used multivariate ordinary least squares linear regression models to examine the association of BPA 
and triclosan with CMV antibody titers, and multivariate logistic regression models to investigate 
the association of these chemicals with allergy or hay fever diagnosis. Statistical models were strati-
fied by age (< 18 years and ≥ 18 years). 
re s u l t s: In analyses adjusted for age, sex, race, body mass index, creatinine levels, family income, 
and educational attainment, in the ≥ 18-year age group, higher urinary BPA levels were associated 
with higher CMV antibody titers (p < 0.001). In the < 18-year age group, lower levels of BPA were 
associated with higher CMV antibody titers (p < 0.05). However, triclosan, but not BPA, showed 
a positive association with allergy or hay fever diagnosis. In the < 18-year age group, higher levels 
of triclosan were associated with greater odds of having been diagnosed with allergies or hay fever 
(p < 0.01). 
co n c l u s i o n s: EDCs such as BPA and triclosan may negatively affect human immune function as 
measured by CMV antibody levels and allergy or hay fever diagnosis, respectively, with differential 
consequences based on age. Additional studies should be done to investigate these findings.
key w o r d s : allergies, bisphenol A, cytomegalovirus, endocrine-disrupting compounds, NHANES, 
triclosan. Environ Health Perspect 119:390–396 (2011).  doi:10.1289/ehp.1002883 [Online 
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agonistic effects of BPA on a mutant andro-
gen receptor in a human prostate adeno-
carcinoma cell line were more pronounced 
at low doses than at higher doses (Keri et al. 
2007). Therefore, EDCs may possess nonlin-
ear dose–response dynamics, with low doses 
causing greater abnormalities. Second, urinary 
BPA levels have not been shown to decline 
consistently with increasing fasting times; this 
finding suggests that dietary exposure may 
not be the only important source of exposure, 
or that BPA is not cleared rapidly from the 
body (Stahlhut et al. 2009; Vandenberg et al. 
2010). Thus, a need exists to better under-
stand how chronic exposure to low doses of 
BPA may affect human health.
Another prevalent EDC, triclosan 
(2,4,4´-trichloro-2´-hydroxydiphenyl ether), 
was first introduced in the 1960s for use in 
personal care products as an antimicrobial 
and preservative. Since then, triclosan has 
been added to countless consumer products, 
including, but not limited to, hand soaps, 
laundry detergents, toothpastes, wound dis-
infection solutions, deodorants, facial tis-
sues, plastic kitchen utensils, medical devices, 
and toys [Centers for Disease Control and 
Prevention (CDC) 2010; U.S. EPA 2010]. 
The proliferation of triclosan as an “antibacte-
rial” ingredient coincides with mounting evi-
dence of its bioaccumulation and persistence 
in human fat tissue, umbilical cord blood, 
human breast milk, and urine (Smith and 
Lourie 2009). The most likely routes of expo-
sure to triclosan are ingestion and absorp-
tion through the skin (Calafat et al. 2008). 
The CDC, in a study conducted from 2003 
through 2004 among a representative sample 
of the U.S. general population ≥ 6 years of 
age, found triclosan at unadjusted concentra-
tions of 2.4–3,790 μg/L in the urine of 75% 
of Americans (Calafat et al. 2008). The sig-
nificance of this finding remains unknown.
Despite the initial safety data demon-
strating triclosan’s tolerance by humans, more 
recent studies have found that it may have 
detrimental effects on the central nervous sys-
tem and may be linked to allergies and asthma 
(Glaser 2004; Kepner 2004–2005). Triclosan 
was first labeled as an EDC in 2006 when 
Veldhoen et al. (2006) demonstrated that tri-
closan (at concentrations as low as 0.15 μg/L) 
decreased body weight and accelerated thy-
roid hormone–mediated hind limb develop-
ment in the bullfrog Rana catesbeiana. Thus, 
triclosan may not mimic thyroid hormones 
but may influence how they act, affecting the 
development and metabolism of not only 
frogs but all species that depend on thyroid 
hormone signaling, including humans.
The ability of chemicals such as BPA 
and triclosan to interfere with the endo-
crine system, and the interactions between 
the endocrine and immune systems, suggests 
that EDCs may also target immune function 
(Ahmed 2000; Chalubinski and Kowalski 
2006). Immunological changes, including 
increased CD4+:CD8+ratios, decreased prolif-
eration of peripheral blood mono  nuclear cells, 
and increased frequency of auto  antibodies, 
have all been observed in humans with occu-
pational exposures to pesticides contain-
ing EDCs (Ahmed 2000; McConnachie 
and Zahalsky 1992; Rosenberg et al. 1999; 
Straube et al. 1999). Yet, no epidemiologi-
cal data have been examined to determine 
whether BPA or triclosan influences immune 
function. Natural estrogen (17β-estradiol) has 
been shown to disrupt morphology of the thy-
mus and bone marrow, protect the main cells 
of the immune system (T, B, and antigen-
presenting cells) from apoptosis, and regulate 
the synthesis of antibodies in the serum and 
female genital tract (Ahmed 2000; Donner 
et al. 1999; Grossman 1984; Verthelyi and 
Ahmed 1998; Wira and Sandoe 1987). It is 
therefore plausible that EDCs such as BPA 
and triclosan, which possess estrogenic activ-
ity (Ishibashi et al. 2004), may exert similar 
effects within the body.
Laboratory studies have also shown that 
EDCs, such as BPA, diethylhexyl phtha-
late, and 4-tert-octylphenol, can be involved 
in the development of allergies by increas-
ing interleukin-4 production and IgE levels 
(Chalubinski and Kowalski 2006; Lee et al. 
2003). For triclosan, some have hypothesized 
that using this antimicrobial ingredient may 
increase allergies among humans via the 
“hygiene hypothesis.” The hygiene hypothesis, 
first proposed by Strachan (1989), has evolved 
into a potential explanation for the increase 
in allergic and autoimmune diseases observed 
in recent decades, particularly in developed 
countries. This hypothesis attributes the rise 
in allergies to the increase in clean, hygienic 
living environments and subsequent decrease 
in exposure to infectious agents (Okada et al. 
2010). Exposure to triclosan and other anti-
bacterial agents may lead to an excessively 
clean environment that disrupts the usual 
development of the immune system by elimi-
nating or changing the commensal microbiota 
that normally help to shape the immune sys-
tem (Levy 2001; Okada et al. 2010).
To begin to address the gaps that exist 
in understanding how environmental expo-
sures and immune dysfunction are related, 
we investigated the association of two EDCs 
with markers of immune function. We 
hypothesized that exposure to BPA and tri-
closan may lead to impaired immune function 
and increased allergies. Using data from the 
2003–2006 NHANES, we examined whether 
urinary levels of BPA and triclosan were associ-
ated with reported allergies or measured serum 
antibody titers to a common pathogen of the 
herpes virus family, cytomegalovirus (CMV). 
Increased CMV antibody titers are consid-
ered a marker of altered cell-mediated immune 
function (Dowd and Aiello 2009; Koch et al. 
2006; McDade et al. 2000; Stowe et al. 2007), 
and high antibody levels indicate that the 
cellu  lar arm of the immune response is less 
effective in keeping the virus in a persistent 
latent state (Roberts et al. 2010). CMV anti-
body levels are useful as a marker of immune 
function because primary infection with this 
virus often occurs at a very young age, the 
virus persists in the infected host for life, and 
containment of the virus becomes a top prior-
ity for the immune system (Dowd and Aiello 
2009; Koch et al. 2006). This study provides 
an important first step toward understanding 
how two prevalent EDCs, BPA and triclosan, 
may interact with human immune function.
Materials and Methods
Data source. We used survey and laboratory 
data from the 2003–2006 U.S. NHANES for 
this study (CDC 2011a, 2011b). NHANES is 
a U.S. nationally representative cross-  sectional 
survey, with interview, examination, and labo-
ratory data collected continuously and released 
in 2-year waves. Participants were chosen via a 
stratified multistage sampling method, with 
oversamples of African Americans, Mexican 
Americans, and persons > 60 years of age.
Outcomes. CMV-specific IgG was meas-
ured in the 2003–2004 wave for respondents 
6–49 years of age using an enzyme-linked 
immunosorbent assay (ELISA) by Quest 
International Inc. (Miami, FL). Serum sam-
ples near the ELISA cutoff were confirmed 
with a second ELISA assay by bioMérieux 
Inc. (Durham, NC). When these two tests 
disagreed, an immunofluorescent assay (IFA) 
from Bion International, Inc. (Des Plaines, 
IL) was performed, and the result of the IFA 
was given as the final result. All assays were 
carried out according to manufacturer guide-
lines. CMV-specific IgG optical density was 
reported [measured in arbitrary units (AU) per 
milliliter] and used as a continuous outcome 
variable. CMV seropositivity was defined 
by NHANES based on this optical density   
measure (CDC 2003a).
A diagnosis of allergy or hay fever was 
determined by two questions in the NHANES 
interview. Respondents were asked, “Has a 
doctor or other health professional ever told 
you that you have allergies/hay fever?” A 
respondent was coded as having allergies or 
hay fever if the response to either question 
was yes.
Predictors. Urinary BPA and triclosan 
were measured in a random subsample of 
one-third of participants > 6 years of age (n = 
5,250). Aliquots (100 μL) of single-void urine 
specimens (spot urine samples) were analyzed 
using solid-phase extraction coupled online 
to high-performance liquid chromatography Clayton et al.
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and tandem mass spectrometry. Analysis was 
conducted by the Division of Environmental 
Health Laboratory Sciences, National Center 
for Environmental Health, CDC, using 
methods previously described (Ye et al. 2005). 
The lower limit of detection for BPA was 
0.36 ng/mL in 2003–2004 and 0.4 ng/mL in 
2005–2006; the lower limit of detection for 
triclosan was 2.27 ng/mL in 2003–2004 and 
2.3 ng/mL in 2005–2006 (CDC 2003b).
Covariates. CDC calculated body mass 
index (BMI) as kilograms per meters squared-
from measured height and weight during 
the exam and measured urinary creatinine in 
micrograms per deciliter and included to con-
trol for the level of dilution of urine analytes. 
We coded family income as the midpoint of 
each of 11 reported income categories. Income 
was adjusted to year 2000 dollars using the 
Consumer Price Index (Bureau of Labor 
Statistics 2011). For the top-coded income 
cate  gory (> $65,000), we used the median fam-
ily income for those with income > $65,000 
(according to the 2000 current population 
survey) (Bureau of Labor Statistics and Bureau 
of the Census 2011). Income was also divided 
into quartiles within each wave. We coded 
race/ethnicity as non-Hispanic white, non-
Hispanic black, Mexican American, and other 
race/ethnic groups (including other Hispanic 
groups). Educational attainment of the house-
hold reference person was coded in three cate-
gories: less than high school, completed high 
school, and more than high school.
Sample. Triclosan and BPA measures were 
available for 5,065 respondents; 541 respon-
dents (10.6%) were missing data on one or 
more covariates, with an additional 796 
respondents missing data on continuous CMV 
or allergy diagnosis, for a final sample of 3,728 
respondents. Regressions of CMV were limited 
to CMV-seropositive respondents with non-
missing CMV optical density measures (avail-
able in the 2003–2004 wave). Regressions were 
also limited to respondents with detected levels 
of BPA (when BPA was a predictor) or triclosan 
(when triclosan was a predictor). Regressions 
including triclosan as a predictor were further 
limited to respondents no more than 50 years 
of age at the time of the exam because triclo-
san was not introduced into the community 
setting until the 1960s, with wide-scale use in 
consumer products occurring in the late 1980s 
and 1990s (Coulborn et al. 2010). This age 
restriction allowed us to analyze a population 
that would have had ample opportunity to 
be exposed to triclosan throughout the entire 
life span. See Figure 1 for details on analytic 
sample breakdown.
Statistical analysis. Ordinary least squares 
(OLS) regressions were used to model con-
tinuous CMV; logistic regressions were used 
to model allergies/hay fever. Two models were 
used to examine the association of triclosan/
BPA with each outcome of interest: Model 1 
included age, sex, creatinine, and race as 
covariates; model 2 included all of these plus 
BMI, family income, and educational attain-
ment. Models were stratified by age (< 18 vs. 
≥ 18 years). We chose to examine the effects 
of triclosan and BPA on immune function 
separately for children and adults, because of 
potential differences in length of exposure to 
triclosan or BPA, immune system develop-
ment, and differences in the prevalence of 
CMV infection, antibody levels, and aller-
gies among children versus adults (Arbes et al. 
2005; Bate et al. 2010; Calafat et al. 2008; 
Dowd and Aiello 2009; LaKind and Naiman 
2010; Vandenberg et al. 2010). All models 
used sampling weights and adjusted for the 
NHANES complex survey design. Analyses 
were conducted using STATA (version 10.0; 
StataCorp LP, College Station, TX).
Figure 1. Analytic sample creation.
20,470 total 2003–2006 NHANES participants
5,065 participants tested for triclosan or bisphenol A (BPA) exposure
4,524 participants with nonmissing covariate data
Descriptive statistics sample: 
3,728 participants with outcome data (tested for CMV or answered allergy question) 
and detectable levels of BPA or triclosan 
BPA/CMV 
analysis sample:
787 participants 
with detectable BPA
levels and CMV
seropositivity 
Triclosan/CMV
analysis sample:
620 participants with
detectable triclosan
levels, CMV
seropositivity, and
< 50 years old   
BPA/allergy 
analysis sample:
2,133 participants
with detectable BPA
levels who answered
allergy question 
Triclosan/allergy
analysis sample:
1,444 participants with 
detectable triclosan 
levels who answered 
allergy question and 
are < 50 years old 
Table 1. Estimated population means and frequencies for demographic characteristics of study population, 
NHANES 2003–2006.
Characteristic
Weighted mean or 
percentage (95% CI) Linearized SE n
Age (years) 35 (33.36–35.82) 0.60 3,728
Male (%) 50.5 (48–53) 1.10 3,728
BMI (kg/m2) 26.6 (26.13–27.05) 0.22 3,728
Lab measure
Triclosan (ng/mL) 116.3 (105.43–127.11) 5.31 3,728
BPA (ng/mL) 4.4 (4.07–4.82) 0.18 3,728
CMV seropositive (%) 46.7 (42–52) 2.40 1,496
CMV-antibody level (if seropositive) 2.1 (1.93–2.17) 0.06 805
Creatinine (mg/dL) 134.9 (130.27–139.61) 2.29 3,728
Ever diagnosed with allergies or hay fever (%) 33.8% (31–36) 1.10 2,232
Race (%)
Non-Hispanic white 68.3 (63.3–72.9) 2.40 1,457
Non-Hispanic black 12.9 (1–16.5) 1.60 1,073
Mexican American 9.7 (7.5–12.5) 1.20 933
Other race/ethnic groups 9.1 (7.4–0.11.1) 0.90 265
Family income [US$(2000)] 51,706 (48,809–54,603) 1,418 3,728
Family income quartile [US$(2000)]
1 8,985 894
2 25,108 1,153
3 47,005 736
4 96,102 945
Head of household educational attainment (%)
 < High school 17.2 (15.3–19.2) 1.00 1,044
Completed high school 24.8 (22.6–0.27.2) 1.10 898
 > High school 58.0 (54.8–61.2) 1.60 1,786Bisphenol A, triclosan, and immune parameters
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Results
Demographic characteristics of the study popu­
lation. Table 1 summarizes the physical and 
sociodemographic characteristics of the study 
population (n = 3,728). The mean concentra-
tion of urinary triclosan was > 25 times higher 
than that of BPA (116.3 vs. 4.4 ng/mL). Of 
the 46.7% of the population testing positive 
for CMV IgG antibody, the mean antibody 
level was 2.1 AU/mL. Approximately one-
third of the population (33.8%) reported that 
a doctor had diagnosed them with allergies or 
hay fever at some point during their life.
Triclosan and BPA concentrations by socio­
demographic characteristics. We next examined 
whether mean triclosan and BPA concentrations 
differed by sociodemographic group (Table 2). 
We observed no statistically significant differ-
ences in mean triclosan or BPA levels between 
CMV-seropositive and CMV-seronegative 
individuals, between those with and without 
allergies or hay fever, or across levels of edu-
cational attainment of the head of household. 
Mexican Americans had the highest mean con-
centration of triclosan (160.59 ng/mL), whereas 
non-Hispanic blacks had the highest mean 
concentration of BPA (5.38 ng/mL). Although 
we found no differences in mean BPA con-
centrations between males and females, males 
had significantly higher mean triclosan levels 
than did females (136.76 vs. 95.38 ng/mL). 
Interestingly, both triclosan and BPA concen-
trations differed across family income quartiles, 
but the trend was in the opposite direction: 
Those in the lowest family income quartile had 
significantly higher mean BPA concentrations 
than did those in the highest quartile (5.73 vs. 
3.75 ng/mL) but lower mean concentrations of 
triclosan (94.80 vs. 138.06 ng/mL).
Association between triclosan and BPA, 
and CMV antibody levels. Triclosan levels 
were not significantly associated with CMV 
antibody levels in either age group, regard-
less of whether the models were minimally 
adjusted (for age, sex, race, and creatinine 
levels) or fully adjusted (for additional charac-
teristics such as BMI, family income, and edu-
cational attainment; Table 3). Among those 
≥ 18 years of age, increasing age, and female 
were associated with higher CMV antibody 
levels; adjusting for income and education 
had almost no effect on these associations. For 
BPA, increasing concentrations of BPA were 
associated with increasing CMV antibody 
levels in those ≥ 18 years of age in both mini-
mally and fully adjusted models (Table 4). In 
children and adolescents < 18 years of age, we 
found an inverse relation between BPA levels 
and CMV antibody titers when controlling 
for BMI and socioeconomic position (SEP).
Association between triclosan and BPA, 
and allergies. Higher triclosan levels were asso-
ciated with greater odds of having been diag-
nosed with allergies or hay fever (Table 5). We 
observed this association in both age groups, 
but it was statistically significant only for 
those < 18 years old [odds ratio (OR) = 1.257; 
p < 0.01]. We found no association of BPA 
with allergy or hay fever diagnosis (Table 6). 
Males had higher odds of allergies in the 
younger age group than did females, with the 
reverse pattern in adults.
Discussion
Data on the immune consequences of 
exposure to EDCs are lacking. With the 
interaction of the endocrine, immune, and 
nervous systems, it is likely that EDCs may 
induce pathophysiology not only in the endo-
crine system but also in other human body 
systems. Given the crucial role the immune 
system plays in determining overall health sta-
tus (Dietert et al. 2010), it is essential to begin 
to address the impact of prevalent EDCs, 
including BPA and triclosan, on immune 
parameters.
Our analyses adjusting for physical, demo-
graphic, and socioeconomic characteristics 
Table 2. Estimated mean triclosan and BPA levels, by sociodemographic characteristics, NHANES 
2003–2006.
Triclosan BPA
Characteristic Mean (ng/mL) p-Value Mean (ng/mL) p-Value
CMV 0.741 0.235
Seropositive 103.63 5.53
Seronegative 99.38 4.83
Ever diagnosed with allergies or hay fever 0.814 0.633
Yes 122.76 3.78
No 127.53 4.09
Sex 0.008 0.451
Male 136.76 4.58
Female 95.38 4.31
Race 0.095 < 0.001
Non-Hispanic white 110.56 4.04
Non-Hispanic black 110.74 5.38
Mexican American 160.59 5.32
Other race/ethnic groups 119.56 5.21
Family income quartile 0.119 0.001
1 94.80 5.73
2 103.94 4.61
3 113.41 4.37
4 138.06 3.75
Head of household educational attainment 0.608 0.629
 < High school 121.01 4.51
Completed high school 103.55 4.69
 > High school 120.31 4.32
Mean triclosan and BPA levels are weighted. p-Values are from a Wald test of the difference between these weighted 
means.
Table 3. Association between triclosan levels and immune function measured by CMV antibody levels, 
NHANES 2003–2004.
Model 1 Model 2
Independent variable
< 18 years of age 
(n = 252)
≥ 18 years of age 
(n = 368)
< 18 years of age 
(n = 252)
≥ 18 years of age 
(n = 368)
Ln(triclosan) (ng/mL) 0.003 (0.046) –0.024 (0.031) 0.012 (0.046) –0.022 (0.032)
Age (years) –0.026 (0.014) 0.020 (0.004)*** –0.025 (0.015) 0.021 (0.004)***
Male –0.093 (0.136) –0.316 (0.074)*** –0.130 (0.127) –0.311 (0.079)**
BMI (kg/m2) 0.005 (0.009) –0.003 (0.008)
Creatinine (mg/dL) 0.001 (0.001) 0.001 (0.001) 0.001 (0.001) 0.000 (0.001)
Race
Non-Hispanic black 0.039 (0.101) 0.123 (0.097) 0.077 (0.147) 0.046 (0.111)
Mexican American 0.028 (0.146) 0.093 (0.114) 0.109 (0.209) –0.045 (0.115)
Other race/ethnic groups –0.092 (0.252) –0.081 (0.168) –0.003 (0.260) –0.136 (0.183)
Family income quartile
2 –0.176 (0.150) –0.109 (0.133)
3 –0.276 (0.215) –0.122 (0.117)
4 –0.063 (0.207) –0.353 (0.176)
Head of household education
Completed high school 0.193 (0.185) –0.095 (0.147)
 > High school 0.121 (0.163) –0.096 (0.161)
Data are β-coefficients (SEs) for each independent variable in the regression models. Models are OLS regressions with 
CMV antibody level as the dependent variable, estimated among respondents with detected levels of triclosan. Only 
respondents < 50 years of age are included. Model 1 includes age, sex, creatinine, and race as covariates; model 2 
includes all of these plus BMI, family income, and educational attainment. 
**p < 0.01. ***p < 0.001.Clayton et al.
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indicated that higher levels of urinary BPA, 
but not triclosan, were associated with higher 
CMV antibody levels, suggesting that the 
immune systems of individuals with higher 
BPA exposure are less able to control chronic 
infections. One potential mechanistic expla-
nation for this association is that BPA may 
inhibit macrophage function (Segura et al. 
1999). An important first step in the phago-
cytic function of macrophages is adherence, 
and in vitro exposure of rat peritoneal macro-
phages to BPA has demonstrated suppressed 
macrophage adherence (Segura et al. 1999). 
CMV persists in immune cells of the myeloid 
lineage (Taylor-Wiedeman et al. 1991), such 
as mature monocytes, which can go on to 
develop into macrophages. If BPA disrupts 
the function of macrophages, it may be easier 
for CMV to survive and replicate, increasing 
the need for the host to increase antibody 
production to counteract CMV reactivation.
In a recently published analysis of 2003–
2004 NHANES data, LaKind and Naiman 
(2010) reported significantly higher urinary 
concentrations of BPA in the youngest age 
groups of their study population, compared 
with older age groups. The study also found 
higher urinary BPA levels in men compared 
with women. We observed a similar trend by 
sex in our analyses, but this difference did not 
reach statistical significance. Consistent with 
results from LaKind and Naiman (2010), we 
found that non-Hispanic blacks had signifi-
cantly higher urinary BPA levels than did 
non-Hispanic whites.
It is unclear why BPA was positively asso-
ciated with CMV antibody levels in adults but 
negatively associated with CMV at younger 
ages. The physiological consequences of BPA 
exposure may vary based on the quantity, 
duration, and/or timing of exposure. Short 
exposures to BPA—and potentially other 
EDCs—may provide a measure of positive 
immune stimulation, whereas longer exposures 
could tip the balance toward immune dysfunc-
tion. One example of an EDC that has been 
shown to possess both beneficial and harmful 
effects is the iso  flavone genistein. Although 
naturally occurring (unlike BPA), genistein 
has been identified as an EDC because of its 
ability to exhibit estrogenic activity, its asso-
ciation with reproductive problems in animals, 
and its link to adenocarcinomas and mam-
mary tumors in rodents. A potential bene-
fit of isoflavones such as genistein is antiviral 
properties against a variety of virus families 
in both in vitro and in vivo studies (Andres 
et al. 2009). The mechanism of this antiviral 
activity is unknown, but isoflavones have been 
shown to exert effects on both the virus and 
the host (Andres et al. 2009). Thus, BPA may 
initially pose a larger threat to CMV than to 
the human host, with the relation shifting over 
time as immunosenescent changes occur with 
aging, leading to immune dysfunction and 
higher CMV antibody levels. Further studies 
are needed to address the potential immune-
boosting effects BPA may have in naive 
immune systems, as well as the detrimental 
effects shown here on adults with developed 
immune systems.
In individuals < 18 years of age, higher 
concentrations of urinary triclosan were asso-
ciated with greater odds of having been diag-
nosed with allergies even after adjusting for 
age, sex, BMI, race, and family income and 
education. The “hygiene hypothesis” argues 
that the developing human immune system 
needs exposure to commensal microorganisms 
for proper stimulation of T helper 1 (TH1) and 
TH2 cells (Okada et al. 2010). Most individu-
als with allergies have an imbalance in TH1 and 
TH2 cells, with more TH2 cells that promote 
antibody production (Levy 2001). It is possible 
that exposure to triclosan, particularly at times 
during the life course when the immune sys-
tem is developing, may modify immunological 
responses to microorganisms in such a way that 
imbalances between TH1 and TH2 cells are 
created. These T-cell imbalances may stimulate 
autoimmune reactions and allergies.
Calafat et al. (2008) reported that almost 
75% of the 2003–2004 NHANES partici-
pants studied had measurable amounts of 
Table 4. Association between BPA levels and immune function measured by CMV antibody levels, 
NHANES 2003–2004.
Model 1 Model 2
Independent variable
< 18 years of age 
(n = 335)
≥ 18 years of age 
(n = 452)
< 18 years of age 
(n = 335)
≥ 18 years of age 
(n = 452)
Ln(BPA) (ng/mL) –0.104 (0.053) 0.186 (0.034)*** –0.113 (0.047)* 0.158 (0.035)***
Age (years) –0.011 (0.013) 0.017 (0.004)*** –0.012 (0.012) 0.018 (0.004)***
Male –0.151 (0.117) –0.250 (0.078)** –0.154 (0.109) –0.239 (0.078)**
BMI (kg/m2) 0.004 (0.008) 0.001 (0.006)
Creatinine (mg/dL) 0.001 (0.001)* –0.001 (0.001) 0.001 (0.001)* –0.001 (0.001)
Race
Non-Hispanic black 0.179 (0.086) 0.158 (0.082) 0.145 (0.103) 0.095 (0.093)
Mexican American 0.105 (0.084) 0.128 (0.108) 0.090 (0.097) –0.006 (0.115)
Other race/ethnic groups 0.288 (0.150) –0.111 (0.141) 0.294 (0.154) –0.211 (0.168)
Family income quartile
2 –0.275 (0.134) –0.055 (0.101)
3 –0.275 (0.164) –0.166 (0.099)
4 –0.107 (0.138) –0.305 (0.132)*
Head of household education
Completed high school 0.070 (0.148) –0.136 (0.108)
> High school –0.015 (0.105) –0.136 (0.154)
Data are β-coefficients (SEs) for each independent variable in the regression models. Models are OLS regressions with 
CMV antibody level as the dependent variable. The model is estimated among respondents with detected levels of BPA. 
Model 1 includes age, sex, creatinine, and race as covariates; model 2 includes all of these plus BMI, family income, 
and educational attainment. 
*p < 0.05. **p < 0.01. ***p < 0.001.
Table 5. Association between triclosan levels and immune function measured by allergies or hay fever 
diagnosis: NHANES 2003–2006.
Model 1 Model 2
Independent variable
< 18 years of age 
(n = 678)
≥ 18 years of age 
(n = 766)
< 18 years of age 
(n = 678)
≥ 18 years of age 
(n = 766
Ln(triclosan) (ng/mL) 1.245 (0.109)* 1.004 (0.075) 1.257 (0.097)** 0.996 (0.074)
Age (years) 1.043 (0.029) 1.015 (0.008) 1.023 (0.029) 1.014 (0.009)
Male 1.396 (0.239) 0.624 (0.148) 1.379 (0.229) 0.631 (0.151)
BMI (kg/m2) 1.024 (0.019) 1.004 (0.014)
Creatinine (mg/dL) 0.999 (0.001) 0.999 (0.001) 0.999 (0.002) 0.999 (0.002)
Race
Non-Hispanic black 1.199 (0.313) 0.781 (0.201) 1.303 (0.354) 0.803 (0.223)
Mexican American 0.439 (0.135)* 0.578 (0.130)* 0.588 (0.190) 0.755 (0.202)
Other race/ethnic groups 1.202 (0.417) 0.807 (0.261) 1.226 (0.456) 0.880 (0.269)
Family income quartile
2 0.691 (0.334) 1.216 (0.349)
3 0.498 (0.146)* 0.801 (0.298)
4 0.760 (0.295) 1.099 (0.351)
Head of household education
Completed high school 2.488 (0.855)* 1.638 (0.568)
> High school 3.107 (1.209)* 2.198 (0.665)*
Data are ORs (SEs) for allergy or hay fever diagnosis among unit changes (or categories) of the independent variable. 
Models are logistic regressions with dependent variable ever diagnosed with allergies or hay fever, estimated among 
respondents with detected levels of triclosan. Only respondents < 50 years of age are included. Model 1 includes age, sex, 
creatinine, and race as covariates; model 2 includes all of these plus BMI, family income, and educational attainment. 
*p < 0.05. **p < 0.01Bisphenol A, triclosan, and immune parameters
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triclosan in their urine. Triclosan concentra-
tions ranged from 2.4 to 3,790 μg/L, with 
the highest levels occurring in young adults 
in their 20s and those of higher SEP (Calafat 
et al. 2008). In the analyses we present here, 
higher SEP (as measured by family income 
levels) was also associated with higher uri-
nary triclosan concentrations. In multivariate 
logistic regression models, individuals living 
in households where the head of household 
was more educated had greater odds of ever 
having been diagnosed with allergies and/or   
hay fever. Although asthma and wheezing 
are more common in persons of lower SEP 
(McHugh et al. 2009), hay fever and eczema 
seem to be more common in non-Hispanic 
whites and persons of higher SEP (Litonjua 
et al. 2005). Thus, it may be that triclosan 
exposure is associated more with atopic dis-
orders often seen in high-SEP populations 
than it is with asthma-related allergies that are 
more common among those of lower SEP.
Limitations to the present study include 
its cross-sectional nature, which prohibits any 
investigation of temporality and therefore does 
not provide a definitive causal pathway for 
triclosan or BPA as they relate to alterations 
in immune function. Further biological stud-
ies examining the pathways by which these 
chemicals may influence the human immune 
system are warranted. We also did not address 
the impact of mixture effects, so it is possible 
that triclosan or BPA alone may not be at the 
origin of the described effects. In addition, we 
determined body levels of these chemicals by 
urinary concentrations, which may not be as 
physiologically relevant as the free concentra-
tions of triclosan or BPA in the bloodstream 
(Vandenberg et al. 2010). Furthermore, we 
did not consider important factors that may 
affect the relation of triclosan and BPA to 
immune function, such as psychosocial stress 
and genetics, because of limitations in the data 
collected. Given that the allergy/hay fever out-
come was self-reported from previous phy-
sician diagnosis, some bias may exist in this 
variable if participants who have allergies or 
hay fever have not seen a doctor and been 
diagnosed. Although CMV antibody levels 
have proven to be an important indicator of 
cellular immune function and allergy or hay 
fever provides a good indication of the TH2 
arm of the immune system, few other mea-
sures of immune function were available in 
NHANES for the age range included in our 
analyses. Future studies should examine cellu-
lar phenotypic markers and function to assess 
whether the results here are supported by a 
broader set of markers involved in immune 
alterations. Finally, the sample sizes for each 
age-stratified model limit our power to detect 
very small effects on the immune parameters 
of interest. Because of these limitations, more 
studies are needed to address the impact of 
BPA and triclosan on immune function and 
duplicate the findings we report.
Conclusions
This novel study addresses the need to improve 
our understanding of how EDCs affect human 
health, particularly immune function. Using 
data from a nationally representative sample, 
this study is the first to our knowledge that 
demonstrates an association between BPA lev-
els and CMV antibody levels, and one of the 
first to examine associations between triclosan 
concentrations and allergy or hay fever diag-
nosis. These results suggest that EDCs such 
as BPA and triclosan negatively alter immune 
function over the life course, in addition to 
posing a threat to endocrine and reproductive 
function. There is an urgent need to identify 
the under  lying mechanisms of EDC-mediated 
immune dysfunction. Future studies should 
seek to elucidate these mechanisms, as well as 
how the timing and quantity of exposure to 
EDCs such as triclosan and BPA over the life 
course influence immune function and later-
life disease susceptibility and severity. In addi-
tion, research in the fields of environmental 
health and infectious disease should consider 
how combined exposures to environmen-
tal toxicants and infectious agents may alter 
immune function and subsequent disease risk.
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